The expansion comes at a time when demand for precise outcome data is rising, particularly for shoulder and elbow conditions that affect nearly 2 million Americans annually due to rotator cuff injuries. The 2026 Annual Report marks a technical milestone for the program by incorporating implant component-level data, allowing clinicians to analyze treatment patterns with greater granularity.
Carolyn M. Hettrich, chair of the AAOS Shoulder & Elbow Registry Steering Committee, noted that such partnerships provide the necessary resources to transform raw procedural data into actionable clinical insights. Damien McDonald, CEO of Enovis, emphasized that the collaboration aligns with the company’s broader focus on generating evidence to drive innovation in arthroplasty. The registry, which draws expertise from groups including the American Shoulder and Elbow Surgeons and the American Orthopaedic Society for Sports Medicine, serves as a growing repository for refining patient care standards across the musculoskeletal field.




Comments (0)
No comments yet. Be the first!